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Abstract
PEETERS, ANNA, LUC BONNEUX, WILMA J.
NUSSELDER, CHRIS DE LAET, AND JAN J.
BARENDREGT. Adult obesity and the burden of disability
throughout life. Obes Res. 2004;12:1145–1151.
Objective: To analyze the prevalence of disability through-
out life and life expectancy free of disability, associated
with obesity at ages 30 to 49 years.
Research Methods and Procedures: We used 46 and 20
years of mortality follow-up, respectively, for 3521 Original
and 3013 Offspring Framingham Heart Study participants
30 to 49 years and classified as normal weight, overweight,
or obese at baseline. Disability measures were available
between 36 and 46 years of follow-up for 1352 Original
participants and at 20 years of follow-up for 2268 Offspring
participants. We measured the odds of disability in the
Original cohort after 46 years follow-up, and we estimated
life expectancy with and without disability from age 50.
Two disability measures were used, one representing limi-
tations with mobility only and the second representing lim-
itations with activities of daily living (ADL).
Results: Obesity at ages 30 to 49 years was associated with
a 2.01-fold increase in the odds of ADL limitations 46 years
later. Nonsmoking adults who were obese between 30 and
49 years lived 5.70 (95% confidence interval, 4.11 to 7.35)
(men) and 5.02 (95% confidence interval, 3.36 to 6.61)
(women) fewer years free of ADL limitations from age 50
than their normal-weight counterparts. There was no signif-
icant difference in the total number of years lived with
disability throughout life between those obese or normal
weight, due to both higher disability prevalence and higher
mortality in the obese population.
Discussion: Obesity in adulthood is associated with an
increased risk of disability throughout life and a reduction in
the length of time spent free of disability, but no substantial
change in the length of time spent with disability.
Key words: functional disability, aging, life expectancy,
adult overweight
Introduction
The prevalence of obesity is increasing rapidly in young
adults (1–3). With the uncertainties surrounding weight loss
strategies and associated health benefits, prevention before
adulthood has the greatest chance of reducing the health
burden of obesity (3–5). To understand the potential impact
of public health and lifestyle choices at these young ages, an
awareness of the long-term health consequences of obesity
is needed. We have recently described that obesity at 30 to
49 years is associated with an 6-year lesser life expect-
ancy when compared with that of normal weight individuals
(6). However, equally, if not more, powerful factors in
making lifestyle choices are disability and functional depen-
dence at older ages. These are particularly important for
obesity, where increased mortality is only one part of its
disease burden (7).
Obesity has been suggested to lead to an increased risk of
disability through a range of mechanisms, including skeletal
stress and atherogenesis (8). Because obesity in adulthood
predicts a range of risk factors (obesity and hypertension)
and diseases (diabetes, cardiovascular disease, and osteoar-
thritis) at older ages that are associated with increased
disability (9–11), we expect that adult obesity is associated
with greater disability at older ages. At least three studies
have shown that obesity in those 25 to 74 years can predict
increased disability up to 20 years later (8,9,12). However,
the wide age ranges at baseline and the medium-term fol-
low-up periods in these studies do not allow us to determine
whether obesity before middle age continues to predict
increased disability in old age. The impact of the potentially
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increased age-specific risk of disability on the lifetime ex-
perience of disability is also unknown. Because obesity is
associated with a large decrease in life expectancy, and
because the risk of disability increases sharply with age,
those obese before middle age may actually live fewer years
disabled than the normal-weight population.
Using long-term follow-up from the Framingham Heart
Studies (FHSs),1 we aimed to determine to what extent
overweight and obesity in adulthood (30 to 49 years) are
associated with an increased risk of disability throughout
life. We also aimed to determine whether overweight and
obesity before middle age are associated with a difference in
the duration of life spent with disability compared with
those who are normal weight.
Research Methods and Procedures
Data
The Original FHS has followed 5209 adults, ages 28
through 62 years, since 1948 (13). We used data from the
first 24 biennial exams (46 years follow-up). To capture
disability at younger ages, we used the Offspring study,
which used similar methods to follow 5124 individuals from
1970. We used 20-year follow-up data. We selected per-
sons 30 to 49 years of age [n  3607 (Original), n  3058
(Offspring)] with complete baseline measures for height,
weight, and smoking status and excluded those underweight
(BMI  18.5 kg/m2) at baseline (13,14). This resulted in
3521 Offspring and 3013 Original participants eligible at
baseline. Mortality data were available throughout fol-
low-up for all participants. BMI was calculated as weight in
kilograms/height in meters squared. We defined three BMI
categories: normal weight, BMI of 18.5 to 24.9 kg/m2;
overweight, BMI of 25 to 29.9 kg/m2; and obese, BMI 30
kg/m2.
Consistent data on disability were not collected in the
Original study until exam 19 (36 years postbaseline) and in
the Offspring study until exam 5 (20 years postbaseline), by
which time 43% of the Original cohort and 9% of the
Offspring cohort had died. Figure 1 illustrates the time
scheme of the data used in this study. The analyses on
disability involved those 1352 Original and 2268 Offspring
participants who had complete responses for the disability
measures at exams 19 and 5, respectively.
We analyzed the effect of potential confounders on the
relationship between obesity and disability (15–17) using
complete cases. Baseline measures of mean systolic and
mean diastolic blood pressure, history of cardiovascular
disease, and diabetes status were available for all partici-
pants. Level of education was available for 1318 (97%)
Original participants and 1970 (87%) Offspring partici-
pants. Smoking status was defined as self-reported current
smoker, ex-smoker, or never smoker and was recorded at
99.7% (Original) and 99.9% (Offspring) of exams where
disability status was measured.
Disability
Disability was measured consistently at 36 (exam 19), 38
(exam 20), 40 (exam 21), 42 (exam 22), 44 (exam 23), and
46 (exam 24) years postbaseline in the Original study and at
20 years postbaseline (exam 5) in the Offspring study.
Disability scores were derived from the answers to the
question (18–20), “In a normal day, how do you carry out
the following activities?” for each of 6 activities. The re-
sponses were: 0, with no help; 1, using a device; 2, with
human assistance; and 3, dependent. The activities were: a,
dressing; b, grooming/bathing; c, feeding/eating; d, trans-
ferring (defined as getting in and out of a chair); e, walking
on a level surface (50 yards); and f, walking up and down
one flight of stairs (five steps). In exam 19, question f was
10 steps and thereafter 5. Question c was worded as feeding
1 Nonstandard abbreviations: FHS, Framingham Heart Study; ADL, activities of daily
living; LE, life expectancy; CI, confidence interval.
Figure 1: Schematic representation of the data collected from the
FHS Original and Offspring cohorts. Body mass index was defined
at baseline (exam 1) for both studies. Mortality information was
collected throughout the entire follow-up for each study. Disability
information was collected at each of the illustrated exams after
exam 1 (exams 19 to 24 Original and exam 5 Offspring).
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(defined as pouring and drinking a glass of water) in exams
19 and 20, eating in exam 21, eating food and drinking
liquids in exams 22 to 24, and eating in the Offspring study.
The prevalence of dichotomized disability scores was
analyzed. For dichotomization, disability was defined as
nonlimited (response 0) vs. limited (responses 1 to 3). At a
given age, respondents were defined as mobility only-lim-
ited if they had a minimum of one of the two questions e and
f categorized as limited and as activities of daily living
(ADL)-limited if they had a minimum of one of the four
questions a to d categorized as limited. The majority of
those categorized as ADL-limited also had limitations in
walking on a level surface or walking up and down a flight
of stairs. To analyze the level of age-associated disability at
all ages from 50 years, we combined the data from all of the
relevant follow-up exams: the six Original exams between
36 and 46 years follow-up and the single Offspring exam at
20 years follow-up.
Measures of Association
Odds ratios for disability by baseline BMI status were
estimated using logistic regression (SPSS 10, SPSS Inc.
Chicago, IL, USA) on the dichotomized disability mea-
sures. They were estimated after 46 years of follow-up of
the Original study, adjusting for age (including age and age
squared) and sex. Potential confounding by smoking status
(both baseline and at the exam of disability measurement)
and education was addressed by entering these variables
into the analyses. Potential confounding by hypertension
(systolic blood pressure 140 mmHg or diastolic blood
pressure 90 mmHg), diabetes, and cardiovascular disease
at baseline was addressed by selecting the population free of
all these conditions at baseline and repeating the analyses.
Life Expectancy with and without Disability
Life tables from age 50 were estimated from the com-
bined Original and Offspring cases eligible at baseline (n 
6534 for mortality follow-up and 3620 for disability prev-
alence) (Figure 1). The life tables were based on the age-
specific mortality rates and disability prevalence of this
combined cohort. Because approaching mortality may arti-
ficially increase the mortality risks of belonging to the
normal weight group relative to the overweight or obese
group, we selected cases surviving at least two years after
baseline. Because smoking potentially modifies the effect of
BMI on mortality (6,21,22), we estimated our life tables
separately on baseline nonsmokers (n  2917) and smokers
(n  3589). Life table estimation was done in S-plus 2000
(MathSoft Inc., WA, USA). Life tables were derived from
the estimated age-specific mortality rates of each weight
cohort (6). Poisson regression was used to estimate age-
specific mortality rates between ages 50 and 90 based on
sex, age at follow-up, and BMI category (see supplemental
data available on Obesity Research web site for general fit).
The analyses included a sex-by-age interaction term and
assumed an exponential relationship between the mortality
rate and age (23,24). As neither age-by-BMI nor sex-by-
BMI interaction terms were significant, we did not stratify
by sex or BMI group. Life expectancy at age 90 was
assumed to be that of Massachusetts men or women in 1990
for all BMI categories (25).
Combining all of the available disability measures, logis-
tic regression was used to estimate the age-specific disabil-
ity prevalence between 50 and 90 years for each weight
cohort. Sex, age, age2, sex-by-age interaction terms, and
BMI category were used to predict disability prevalence
(see supplemental data available on Obesity Research web
site for fit). Again, as neither age-by-BMI nor sex-by-BMI
interaction terms were significant, we did not stratify by sex
or BMI group. The age-specific disability prevalence was
combined with life tables derived from the age-specific
mortality rates, according to the Sullivan method (26), pro-
ducing life tables for each sex, smoking status, and BMI
group stratum. In essence, the life table follows a cohort of
people defined by BMI at ages 30 to 49 years throughout
life. At each age, it represents the mortality rate and dis-
ability prevalence of this cohort as it ages. The life table
output was life expectancy (LE) with and without disability
from age 50 or age 70. Confidence intervals (CIs) for the
life table measures were calculated using a 5000 replicate
bootstrap procedure. We report the bootstrap bias-correct,
adjusted 95% CI (27).
Results
Survival to the first exam at which disability was mea-
sured was inversely related to BMI category. However,
among survivors, the response rate at this exam did not
differ substantially by BMI category (Table 1). Among
responders, the obese cohort had the lowest levels of edu-
cation, the lowest proportion of smokers, and the highest
levels of blood pressure and prevalent cardiovascular dis-
ease and hypertension (Table 1). Both the overweight and
obese cohorts had similar mean age, approximately one year
older than the normal weight cohorts.
Obesity at ages 30 to 49 years was associated with a
2.21-fold (95% CI, 0.97 to 5.07) increased odds of mobility
only-limitations and a 2.01-fold (95% CI, 1.01 to 4.03)
increased odds of ADL-limitations after 46 years of follow-
up, compared with those of individuals with normal weight,
after adjustment for age and sex. Overweight was associated
with a 1.30-fold (95% CI, 0.88 to 1.92) increased odds of
mobility only-limitations and a 1.50-fold (95% CI, 1.04 to
2.17) increased odds of ADL-limitations after 46 years of
follow-up. Similar odds ratios were seen in analyses also
adjusting for education and smoking status and in analyses
selecting those free of baseline hypertension, diabetes, and
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cardiovascular disease (data not shown). Consequently, we
used the entire population adjusted only for age and sex in
subsequent analyses.
In baseline nonsmokers, the LE of the obese population at
age 50 was 5.86 (95% CI, 4.12 to 7.63) (men) and 5.57
(95% CI, 3.82 to 7.26) (women) years fewer than of those
with normal weight (Figure 2). The LE of the overweight
population at age 50 was 2.53 (95% CI, 1.07 to 3.76) (men)
and 2.33 (95% CI, 0.92 to 3.45) (women) years fewer than
of those with normal weight. The increased risks of mor-
tality and disability were reflected in the overweight and
obese populations having significantly lower LE free of
disability than the normal weight population. Obese non-
smokers lived 5.70 (95% CI, 4.11 to 7.35) (men) and 5.02
(95% CI, 3.36 to 6.61) (women) fewer years free of ADL-
limitations and 6.02 (95% CI, 4.35 to 7.61) (men) and 5.53
(95% CI, 3.76 to 7.34) (women) fewer years free of any
(mobility or ADL) limitations from age 50 compared with
normal weight nonsmokers. Overweight nonsmokers lived
2.48 (95% CI, 1.18 to 3.65) (men), and 2.13 (95% CI, 0.90
to 3.23) (women) fewer years free of ADL-limitations and
2.00 (95% CI, 0.80 to 3.16) (men), and 1.54 (95% CI, 0.35
to 2.65) (women) fewer years free of any (mobility or ADL)
limitations from age 50 (Figure 2). However, due to the
higher mortality in the obese and overweight groups, there
was no significant difference in the years lived with disabil-
ity (mobility or ADL limitations) between those overweight
or obese and those normal weight at baseline.
Table 1. Baseline and follow-up characteristics of those with full disability measures at 36 years (original) or 20
years (offspring) postbaseline
Baseline weight group
(at ages 30 to 49) Normal weight Overweight Obese
Original cohort
n 796 447 109
Baseline
Mean age 37.07 38.20 38.17
Mean BMI 22.42 27.01 33.18
Male (%) 33 51 42
Current smoker (%) 56 52 39
Not high school graduate (%) 28 39 44
Mean systolic blood pressure 122.17 128.66 139.39
History of cardiovascular disease (%) 0.38 0.67 1.83
History of diabetes (%) 0.50 0.00 0.00
Follow-up 36 years
Response rate at exam 19 (%)* 69 68 69
Mean BMI 25.01 28.23 32.36
Offspring cohort
n 1104 849 315
Baseline
Age 38.19 39.31 39.72
BMI 22.52 27.17 33.46
Male (%) 27 70 60
Current smoker (%) 43 42 41
Not high school graduate (%) 6 8 14
Mean systolic blood pressure 117.37 123.58 132.23
History of cardiovascular disease (%) 0.36 1.18 1.59
History of diabetes (%) 0.72 0.59 3.48
Follow-up 20 years
Response rate at exam 5 (%)* 84 82 80
Mean BMI 24.95 28.85 34.78
* Of all those still alive at the relevant exam.
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The nonsignificant differences in LE with disability are a
balance of more years at younger ages and fewer years at
older ages for the overweight and obese populations (Figure
3). From age 70, those obese or overweight at ages 30 to 49
years lived fewer years with disability than the normal
weight population, because of their higher mortality. Where
the point estimates for the life expectancy with disability
tended to differ slightly between weight groups, we cannot
distinguish whether they represent true differences, nonsig-
nificant due to low power, or a lack of a true difference.
For smokers the general changes in LE were the same as
for nonsmokers, with significant losses of LE free of dis-
ability, but slight nonsignificant changes in LE with disabil-
ity associated with overweight and obesity (data not
shown).
Discussion
Obesity at ages 30 to 49 years was associated with an
2-fold increase in the odds of disability (significant for
ADL-limitations and nonsignificant for mobility only-limi-
tations) 46 years later. Overweight was associated with a
significantly increased odds of ADL-limitations, but not
mobility-only limitations. There was no change in these
odds of disability after taking a population free of hyper-
tension, cardiovascular disease, and diabetes at baseline,
suggesting that any causal pathway involving these factors
begins with obesity. The life course result of these increased
risks is that the 6-year difference in LE from age 50 between
obese and normal weight nonsmoking adults is entirely a
loss of years free of disability.
The increased risk of disability associated with obesity
described here is comparable to a number of cross-sectional
and shorter-term follow-up studies (28–30). Other studies
have also found only moderate associations of overweight
with disability risk (8,28–30). The work presented here
demonstrated that these previously observed risks can also
be predicted for old age by obesity before middle age.
Empirically translating cohort measures of risk into LE
with and without disability requires long-term follow-up
data (31). This has the necessary limitation that the popu-
lation is not current. The Original cohort was followed from
1948, so improved prevention and treatment at younger
ages may now lead to less mortality and disability associ-
ated with obesity. However, through combining the Off-
spring and Original cohorts, the results presented here were
based primarily on mortality and disability data collected
from 1970 onwards. It is also known that the Original cohort
was a healthy, selected cohort, which may approximate
recent populations more closely (22,32).
Another limitation of this study is the combination of the
two cohorts. This was done to enable inclusion of disability
at ages younger than 70, as we expect any extra disability
experienced by the obese population to occur at younger
ages. These cohorts have been previously combined for
cardiovascular risk prediction (33), and as related popula-
tions, they have many similar characteristics. Our assump-
tion is that the age-specific mortality and disability rates
estimated from these 2 cohorts represent those of cohorts
who are normal weight, overweight, or obese at ages 30 to
49 years. Although the two cohorts were followed from
different periods, the estimated disability prevalence and
mortality rates generally represented both cohorts well (see
additional figures as supplemental data available on Obesity
Research web site). One exception was that in the few cases
where there was an overlap of ages between the two cohorts,
we found a higher disability prevalence in the Offspring
cohort. In contrast to these findings, a previous study found
that the Original cohort had more disability than the Off-
spring cohort (34). While we used identical data to that
study for the Offspring cohort, we did not have the data used
for the Original cohort, which was measured 20 years earlier
than our first Original disability data. The reason for the
Figure 3: Life years lived with limitations in ADL (dressing,
bathing, eating, or transfer) at each year of age by sex and BMI
category (in nonsmokers). NW, normal weight.
Figure 2: Expected years of life lived with (LED) and without
(LEDF) disability from age 50 according to sex and BMI category
(all nonsmokers at baseline). The life expectancy with disability is
divided into limitations in mobility only and limitations in ADL.
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different disability prevalences between the two cohorts in
our study at ages 70 to 75 years remains unclear and may be
due simply to chance as the numbers involved at these ages
are low.
Finally, there are a number of data limitations that need
consideration. First, the Framingham cohorts consist of
white Americans, so these results are not generalizable to
other ethnic populations. Second, self-reported disability
measures were used. As there is no evidence to date of
differential accuracy by BMI category in reporting of dis-
ability, random misclassification may have diluted some of
the true differences in disability, but the effect of such
random misclassification would not be expected to change
our conclusions. Third, while we adjusted for baseline
smoking and education status, we were unable to adjust for
other potential confounders, such as physical activity, which
have an effect on disability and mortality independently of
obesity. While the high correlation between physical inac-
tivity and obesity means that our results are probably an
acceptable description of the association between adult obe-
sity and lifetime disability, they do not tell us the indepen-
dent effect of the excess weight alone. Finally, low power
meant that we were unable to reach firm conclusions re-
garding some possible differences in LE with disability,
particularly for the overweight population.
Our results confirm other analyses implying that the
increasing prevalence of obesity will lead to higher de-
mands for health care interventions at younger to middle
ages (35). In the obese populations, there was twice as much
time spent disabled at age 60 as in the normal weight
populations. However, this is balanced by increasing de-
mand for disability care at older age in normal weight
populations; the obese population dies earlier and so accrues
less disability at older ages. Consequently, prevention of
obesity should not be expected to reduce population levels
of disability.
To decrease the inequalities in LE free of disability, the
risks of both mortality and disability throughout life asso-
ciated with obesity in adulthood need to be reduced. A
number of mechanisms probably increase these risks, such
as higher future BMI, onset of disease, increased duration of
excess weight, decreased possibilities for protective behav-
ior, such as physical activity, and increased tendencies for
potentially risky behavior, such as rapid or continual
changes in weight. In the sample studied here, the obese
population differed from the normal weight population at
the time of disability measurement in the expected ways:
with a higher BMI and a higher prevalence of diabetes and
cardiovascular disease (data not shown). At the same time,
as we try to identify effective prevention and “cure” strat-
egies for obesity, we also need to identify effective targets
for increasing the life expectancy free of disability in those
who remain obese before middle age. Analyzing this pop-
ulation for the contribution of future risk profiles to future
disability and mortality risks will enable identification of
such targets.
Obesity before middle age is associated with an increased
risk of future disability and mortality and a sizable decrease
in disability-free LE. In terms of LE with disability, the
disability and mortality risks balance each other: obesity
disables at an earlier age but also kills at an earlier age.
Consequently, obesity is not associated with an increase in
LE with disability, and we should not expect successful
prevention to reduce population disability, particularly at
older ages. These results once again underscore the impor-
tance of preventing obesity before middle age. But one
further priority, given current levels of obesity, should be to
decrease the inequalities in healthy life by increasing dis-
ability-free LE in those with obesity in adulthood.
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